Case Report: Erdheim–Chester disease with liver involvement successfully treated with trametinib
Frontiers in Oncology · 29.05.2026 · 16
DOI: 10.3389/fonc.2026.1740236 ↗Kurz gefasst
Fallbericht in der Zeitschrift Frontiers in Oncology, online erschienen am 29.05.2026. Verfasst von Long Chang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China. Die Arbeit nennt 11 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Background
Erdheim–Chester disease (ECD) is a rare form of histiocytosis with various clinical manifestations. Liver involvement has been infrequently reported. Case presentation We report a case of ECD with liver involvement, presenting with progressive elevation of liver enzymes, a manifestation rarely reported in the literature. Follow-up liver function testing and FAPI-PET/CT performed 6 months after initiation of trametinib therapy demonstrated a dramatic response.
Conclusion
Trametinib holds promise as a therapeutic option for patients with non-BRAF-V600E mutant ECD presenting with liver involvement.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
- State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Beijing, China.
- Department of Nuclear Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
- Department of Medical Oncology, National Cancer Center, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Chang, L., Shen, K. N., Luo, Y. P., & Cao, X. X. (2026). Case Report: Erdheim–Chester disease with liver involvement successfully treated with trametinib. Frontiers in Oncology, 16. https://doi.org/10.3389/fonc.2026.1740236
Vancouver
Chang L, Shen KN, Luo YP, Cao XX. Case Report: Erdheim–Chester disease with liver involvement successfully treated with trametinib. Frontiers in Oncology. 2026;16. doi:10.3389/fonc.2026.1740236
BibTeX
@article{Chang2026,
author = {Chang, Long and Shen, Kai-Ni and Luo, Ya-Ping and Cao, Xin-Xin},
title = {Case Report: Erdheim–Chester disease with liver involvement successfully treated with trametinib},
journal = {Frontiers in Oncology},
year = {2026},
volume = {16},
doi = {10.3389/fonc.2026.1740236}
}
EUVIMED